Utah Medical Products, Inc. (UTMD) financial statements and ratios from SEC XBRL: revenue $38.52M (TTM), net margin 29.3%, revenue growth -14.3% YoY, P/E 21.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $38.52M |
| Net Margin | 29.3% |
| Revenue Growth (YoY) | -14.3% |
| EPS Growth (YoY) | -10.6% |
| FCF Growth (YoY) | -40.5% |
| P/E Ratio | 21.6 |
| EV / EBITDA | 11.8 |
| Price / Book | 1.86 |
| Price / Sales | 6.35 |
| FCF Yield | 9.3% |
| DCF Value (model) | $76.71 |
| DCF Upside vs Price | 7.4% |
| Altman Z-Score | 44.70 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
UTMD overview · UTMD earnings · UTMD KPIs · UTMD investor relations · UTMD ownership · UTMD peers · UTMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.